510(k) K913360

ANTI-RETICULIN ANTIBODY (ARA) TEST by Immco Diagnostics, Inc. — Product Code DBL

K913360 is an FDA 510(k) premarket notification submitted by Immco Diagnostics, Inc. for the device "ANTI-RETICULIN ANTIBODY (ARA) TEST". The FDA issued a decision of Substantially Equivalent on Sep 26, 1994. The device falls under product code DBL (Multiple Autoantibodies, Indirect Immunofluorescent, Antigen, Control), a Class II device regulated under 21 CFR 866.5660. Immco Diagnostics, Inc. has 54 other 510(k) clearances on record.

Clearance details

Decision
SESE (Substantially Equivalent)
Decision Date
Sep 26, 1994
Date Received
Jul 29, 1991
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device classification

Device Name
Multiple Autoantibodies, Indirect Immunofluorescent, Antigen, Control
Device Class
Class II
Regulation Number
866.5660
Review Panel
IM
Submission Type
510(k)

Need the full FDA record for Immco Diagnostics, Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.

Get a free API key

How the connector works

Source: FDA 510(k) database entry for K913360. Report a data issue: hello@regdatalab.com.